John Militello - Aug 17, 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
VP, Principal Accounting Officer and Interim Principal Financial Officer
Signature
/s/ Martin Wilson, as attorney-in-fact for John Militello
Stock symbol
RCKT
Transactions as of
Aug 17, 2023
Transactions value $
-$4,394
Form type
4
Date filed
8/21/2023, 04:05 PM
Previous filing
Aug 15, 2023
Next filing
Oct 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale -$4.39K -284 -4.85% $15.47 5.57K Aug 17, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.

Remarks:

VP, Principal Accounting Officer and Interim Principal Financial Officer